Track: Cancer Drugs Market

Sub-Track:
An increase in the emergence of different cancer conditions, a rise in the popularity of novel therapies, and an increase in the worldwide geriatric population are driving the expansion of the global oncology/cancer medications market. Because of increased cancer awareness and the availability of cancer medications, the market is likely to grow. On the other hand, market growth is likely to be constrained by the high cost of new drug development, as well as the risk of failure and adverse effects associated with cancer treatment therapies.
Market players are projected to benefit from the rising number of pipeline items and the great potential of emerging economies in the future. The Asia-Pacific oncology pharmaceuticals market is expected to grow at a 9.4% CAGR over the next five years.
· Targeted therapy segment
Scientific Highlights
- Cancer therapy and research
- Cancer biology
- Cancer- Types and Causes
- Organ Specific Cancer
- Cancer Imaging Techniques
- Cancer Genomics and Epigenetics
- Cancer Biomarkers
- Stem Cell and Cancer Therapy
- Cancer Biopsy & Surgical Cancer
- Cancer Drugs Market
- Cancer Prevention and awareness
- Cancer Nanotechnology
- Cancer Pharmacology & Immunology
- Neuro Oncology
- Radiation Oncology
- Oncology Nursing and Care
- Clinical Trials of cancer
- Carcinogenesis
- Cancer Metastasis
- Diagnosis & Treatment of cancer